The impact of TP53BP1 and MLH1 on metastatic capability in cases of locally advanced prostate cancer and their usefulness in clinical practice-Reference-Cited by-同舟云学术

The impact of TP53BP1 and MLH1 on metastatic capability in cases of locally advanced prostate cancer and their usefulness in clinical practice

Published:2020-06 Issue:6 Volume:38 Page:600.e17-600.e26
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Gzil Arkadiusz,Jaworski Damian^ORCID,Antosik Paulina^ORCID,Zarębska Izabela,Durślewicz Justyna,Dominiak Joanna,Kasperska Anna,Neska-Długosz Izabela,Grzanka Dariusz,Szylberg Łukasz

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference70 articles.

1. European cancer mortality predictions for the year 2017, with focus on lung cancer;Malvezzi;Ann Oncol,2017

2. Risk of prostate carcinoma death in patients with lymph node metastasis;Cheng;Cancer,2001

3. The impact of lymph node metastases burden at radical prostatectomy;Preisser;Eur Urol Focus,2018

4. High-risk prostate cancer-classification and therapy;Chang;Nat Rev Clin Oncol,2014

5. Integrative genomic profiling of human prostate cancer;Taylor;Cancer Cell,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Family History, Race/Ethnicity, and Genetic Risk on Prostate Cancer Detection and Outcomes: Considerations in PSA-based Screening;Urologic Oncology: Seminars and Original Investigations;2024-07

2. Recent Research Advances in Double-Strand Break and Mismatch Repair Defects in Prostate Cancer and Potential Clinical Applications;Cells;2023-05-12